annual CFF:
$27.01M-$175.74M(-86.68%)Summary
- As of today (June 26, 2025), KRYS annual cash flow from financing activities is $27.01 million, with the most recent change of -$175.74 million (-86.68%) on December 31, 2024.
- During the last 3 years, KRYS annual CFF has fallen by -$320.67 million (-92.23%).
- KRYS annual CFF is now -92.23% below its all-time high of $347.69 million, reached on December 31, 2021.
Performance
KRYS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$12.47M-$14.89M(-613.43%)Summary
- As of today (June 26, 2025), KRYS quarterly cash flow from financing activities is -$12.47 million, with the most recent change of -$14.89 million (-613.43%) on March 31, 2025.
- Over the past year, KRYS quarterly CFF has dropped by -$23.05 million (-217.79%).
- KRYS quarterly CFF is now -106.17% below its all-time high of $202.07 million, reached on December 31, 2021.
Performance
KRYS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$3.96M-$23.05M(-85.32%)Summary
- As of today (June 26, 2025), KRYS TTM cash flow from financing activities is $3.96 million, with the most recent change of -$23.05 million (-85.32%) on March 31, 2025.
- Over the past year, KRYS TTM CFF has dropped by -$207.89 million (-98.13%).
- KRYS TTM CFF is now -98.86% below its all-time high of $347.69 million, reached on December 31, 2021.
Performance
KRYS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KRYS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -86.7% | -217.8% | -98.1% |
| 3 y3 years | -92.2% | -2200.0% | -98.0% |
| 5 y5 years | -74.9% | -5230.0% | -96.3% |
KRYS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -92.2% | at low | -106.7% | at low | -98.3% | at low |
| 5 y | 5-year | -92.2% | at low | -106.2% | at low | -98.9% | at low |
| alltime | all time | -92.2% | +731.5% | -106.2% | at low | -98.9% | +1221.7% |
KRYS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$12.47M(-613.4%) | $3.96M(-85.3%) |
| Dec 2024 | $27.01M(-86.7%) | $2.43M(-27.8%) | $27.01M(-0.7%) |
| Sep 2024 | - | $3.37M(-68.4%) | $27.20M(-26.9%) |
| Jun 2024 | - | $10.64M(+0.5%) | $37.23M(-82.4%) |
| Mar 2024 | - | $10.58M(+304.1%) | $211.86M(+4.5%) |
| Dec 2023 | $202.75M(+473.6%) | $2.62M(-80.4%) | $202.75M(-0.2%) |
| Sep 2023 | - | $13.39M(-92.8%) | $203.20M(+5.9%) |
| Jun 2023 | - | $185.27M(>+9900.0%) | $191.93M(+413.7%) |
| Mar 2023 | - | $1.47M(-52.0%) | $37.36M(+5.7%) |
| Dec 2022 | $35.35M(-89.8%) | $3.07M(+44.8%) | $35.35M(-84.9%) |
| Sep 2022 | - | $2.12M(-93.1%) | $234.35M(+0.3%) |
| Jun 2022 | - | $30.70M(-5764.2%) | $233.74M(+15.2%) |
| Mar 2022 | - | -$542.00K(-100.3%) | $202.84M(-41.7%) |
| Dec 2021 | $347.69M(+194.6%) | $202.07M(>+9900.0%) | $347.69M(+138.5%) |
| Sep 2021 | - | $1.51M(-857.8%) | $145.75M(+0.9%) |
| Jun 2021 | - | -$199.00K(-100.1%) | $144.41M(-44.9%) |
| Mar 2021 | - | $144.30M(>+9900.0%) | $262.08M(+122.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $118.02M(+9.8%) | $141.00K(-15.1%) | $118.02M(-0.1%) |
| Sep 2020 | - | $166.00K(-99.9%) | $118.18M(-9.9%) |
| Jun 2020 | - | $117.47M(>+9900.0%) | $131.18M(+21.8%) |
| Mar 2020 | - | $243.00K(-18.7%) | $107.73M(+0.2%) |
| Dec 2019 | $107.53M(+45.6%) | $299.00K(-97.7%) | $107.53M(-37.3%) |
| Sep 2019 | - | $13.17M(-86.0%) | $171.51M(+2.2%) |
| Jun 2019 | - | $94.02M(>+9900.0%) | $167.90M(+127.3%) |
| Mar 2019 | - | $40.00K(-99.9%) | $73.88M(+0.0%) |
| Dec 2018 | $73.85M(+42.6%) | $64.29M(+573.2%) | $73.85M(+732.9%) |
| Sep 2018 | - | $9.55M(>+9900.0%) | $8.87M(-82.1%) |
| Jun 2018 | - | $4000.00(-33.3%) | $49.48M(-3.9%) |
| Mar 2018 | - | $6000.00(-100.9%) | $51.47M(-0.6%) |
| Dec 2017 | $51.77M(+1493.4%) | -$693.00K(-101.4%) | $51.77M(-1.3%) |
| Sep 2017 | - | $50.16M(+2409.4%) | $52.46M(+2181.9%) |
| Jun 2017 | - | $2.00M(+566.3%) | $2.30M(+666.3%) |
| Mar 2017 | - | $300.00K | $300.00K |
| Dec 2016 | $3.25M | - | - |
FAQ
- What is Krystal Biotech annual cash flow from financing activities?
- What is the all time high annual CFF for Krystal Biotech?
- What is Krystal Biotech annual CFF year-on-year change?
- What is Krystal Biotech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Krystal Biotech?
- What is Krystal Biotech quarterly CFF year-on-year change?
- What is Krystal Biotech TTM cash flow from financing activities?
- What is the all time high TTM CFF for Krystal Biotech?
- What is Krystal Biotech TTM CFF year-on-year change?
What is Krystal Biotech annual cash flow from financing activities?
The current annual CFF of KRYS is $27.01M
What is the all time high annual CFF for Krystal Biotech?
Krystal Biotech all-time high annual cash flow from financing activities is $347.69M
What is Krystal Biotech annual CFF year-on-year change?
Over the past year, KRYS annual cash flow from financing activities has changed by -$175.74M (-86.68%)
What is Krystal Biotech quarterly cash flow from financing activities?
The current quarterly CFF of KRYS is -$12.47M
What is the all time high quarterly CFF for Krystal Biotech?
Krystal Biotech all-time high quarterly cash flow from financing activities is $202.07M
What is Krystal Biotech quarterly CFF year-on-year change?
Over the past year, KRYS quarterly cash flow from financing activities has changed by -$23.05M (-217.79%)
What is Krystal Biotech TTM cash flow from financing activities?
The current TTM CFF of KRYS is $3.96M
What is the all time high TTM CFF for Krystal Biotech?
Krystal Biotech all-time high TTM cash flow from financing activities is $347.69M
What is Krystal Biotech TTM CFF year-on-year change?
Over the past year, KRYS TTM cash flow from financing activities has changed by -$207.89M (-98.13%)